Among the KMT2 family (KMT2A–KMT2G), KMT2A is uniquely implicated in hematologic malignancies due to its essential role in hematopoietic stem cell (HSC) differentiation and its propensity for chromosomal rearrangements [15, 16]. This evidence concerns the gene KMT2A and hematologic disorder.